Gladius Capital Management’s Medtronic MDT Stock Holding History

Gladius Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-178	Closed	-$19K	–	312
2021 Q4	$19K	Buy	178 +44	+33%	+$5.09K	﹤0.01%	300
2021 Q3	$17K	Sell	134 -202	-60%	-$26.1K	﹤0.01%	116
2021 Q2	$42K	Buy	336 +234	+229%	+$29.4K	﹤0.01%	118
2021 Q1	$13K	Buy	+102	New	+$12K	﹤0.01%	166
2020 Q4	–	Sell	-3,328	Closed	-$366K	–	180
2020 Q3	$346K	Buy	+3,328	New	+$334K	0.03%	142
2020 Q2	–	Sell	-11,175	Closed	-$1.01M	–	83
2020 Q1	$1.01M	Buy	11,175 +10,207	+1,054%	+$1.09M	0.11%	88
2019 Q4	$110K	Sell	968 -1,904	-66%	-$209K	0.01%	155
2019 Q3	$312K	Buy	+2,872	New	+$300K	0.01%	189
2019 Q2	–	Sell	-2,636	Closed	-$240K	–	174
2019 Q1	$240K	Sell	2,636 -127	-5%	-$11.4K	0.01%	122
2018 Q4	$251K	Buy	+2,763	New	+$258K	0.01%	122

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Gladius Capital Management's MDT Position: Q1 2022 in Review

Gladius Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 178 shares — an estimated $19K sold.

Gladius Capital Management first reported a position in MDT in Q4 2018 and held it in 10 quarters. The position peaked at $1.01M in Q1 2020. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Gladius Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Gladius Capital Management sold 178 Medtronic shares in Q1 2022, an estimated $19K.
Gladius Capital Management first reported a position in Medtronic in Q4 2018 and held it in 10 quarters.
Gladius Capital Management's Medtronic position peaked at $1.01M in Q1 2020.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Gladius Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.